Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value

被引:5
作者
Jajodia, A. [1 ]
Mandal, G. [2 ]
Yadav, V [2 ]
Khoda, J. [1 ]
Goyal, J. [1 ]
Pasricha, S. [3 ]
Puri, S. [1 ]
Dewan, A. [2 ]
机构
[1] Rajiv Gandhi Canc Inst, Dept Radiol, Delhi, India
[2] Rajiv Gandhi Canc Inst, Dept Surg Oncol, Delhi, India
[3] Rajiv Gandhi Canc Inst, Dept Lab & Histopathol, Delhi, India
关键词
SQUAMOUS-CELL CARCINOMA; HEAD; CHEMORADIOTHERAPY; CANCER;
D O I
10.3174/ajnr.A7553
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: The NI-RADS lexicon doesn't use ADC parameters and T2 weighted signal for ascribing categories. We explored ADC, DWI, and T2WI to examine the diagnostic accuracy in primary sites of postsurgical oral cavity carcinoma in the Neck Imaging Reporting and Data System (NI-RADS) categories 2 and 3. MATERIALS AND METHODS: We performed a retrospective analysis in clinically asymptomatic post-surgically treated patients with oral cavity squamous cell carcinoma who underwent contrast-enhanced MRI between January 2013 and January 2016. Histopathology and follow-up imaging were used to ascertain the presence or absence of malignancy in subjects with ?new enhancing lesions, " which were interpreted according to the NI-RADS lexicon by experienced readers, including NI-RADS 2 and 3 lesions in the primary site. NI-RADS that included T2WI and DWI (referred to as NI-RADS A) and ADC (using the best cutoff from receiver operating characteristic curve analysis, NI-RADS B) was documented in an Excel sheet to up- or downgrade existing classic American College of Radiology NI-RADS and calculate diagnostic accuracy. RESULTS: Sixty-one malignant and 23 benign lesions included in the study were assigned American College of Radiology NI-RADS 2 (n = 33) and NI-RADS 3 (n = 51) categories. The recurrence rate was 90% (46/51) for NI-RADS three, 45% (15/33) for NI-RADS 2, and 73% (61/84) overall. T2WI signal morphology was intermediate in 45 subjects (53.5%) and restricted DWI in 54 (64.2%). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of the American College of Radiology NI-RADS were the following: NI-RADS (75.4%, 78.3%, 90.1%, 54.5%, and 76.1%); NI-RADS A (79.1%, 81.2%, 91.9%, 59.1%, and 79.6%); and NI-RADS B (88.9%, 72.7%, 91.4%, 66.7%, and 85.1%), respectively. CONCLUSIONS: Adding MR imaging diagnostic characteristics like T2WI, DWI, and ADC to the American College of Radiology NI-RADS improved diagnostic accuracy and sensitivity.
引用
收藏
页码:1018 / 1023
页数:6
相关论文
共 16 条
[1]   ACR Neck Imaging Reporting and Data Systems (NI-RADS): A White Paper of the ACR NI-RADS Committee [J].
Aiken, Ashley H. ;
Rath, Tanya J. ;
Anzai, Yoshimi ;
Branstetter, Barton F. ;
Hoang, Jenny K. ;
Wiggins, Richard H. ;
Juliano, Amy F. ;
Glastonbury, Christine ;
Phillips, C. Douglas ;
Brown, Richard ;
Hudgins, Patricia A. .
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2018, 15 (08) :1097-1108
[2]   Implementation of a Novel Surveillance Template for Head and Neck Cancer: Neck Imaging Reporting and Data System (NI-RADS) [J].
Aiken, Ashley H. ;
Farley, April ;
Baugnon, Kristen L. ;
Corey, Amanda ;
El-Deiry, Mark ;
Duszak, Richard ;
Beitler, Jonathan ;
Hudgins, Patricia A. .
JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2016, 13 (06) :743-746
[3]   MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter [J].
Ailianou, A. ;
Mundada, P. ;
De Perrot, T. ;
Pusztaszieri, M. ;
Poletti, P. -A. ;
Becker, M. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (04) :748-755
[4]   MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria [J].
Ashour, M. M. ;
Darwish, E. A. F. ;
Fahiem, R. M. ;
Abdelaziz, T. T. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2021, 42 (06) :1123-1129
[5]   NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma [J].
Baugnon, Kristen L. .
NEUROIMAGING CLINICS OF NORTH AMERICA, 2022, 32 (01) :1-18
[6]   Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes [J].
Chang, Jer-Hwa ;
Wu, Chia-Che ;
Yuan, Kevin Sheng-Po ;
Wu, Alexander T. H. ;
Wu, Szu-Yuan .
ONCOTARGET, 2017, 8 (33) :55600-55612
[7]   Retrospective Evaluation of NI-RADS for Detecting Postsurgical Recurrence of Oral Squamous Cell Carcinoma on Surveillance CT or MRI [J].
Dinkelborg, Patrick ;
Ro, Sa-Ra ;
Shnayien, Seyd ;
Schaafs, Lars-Arne ;
Koerdt, Steffen ;
Kreutzer, Kilian ;
Heiland, Max ;
Hamm, Bernd ;
Elsholtz, Fabian Henry Juergen .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (01) :198-206
[8]   Reliability of NI-RADS criteria in the interpretation of contrast-enhanced magnetic resonance imaging considering the potential role of diffusion-weighted imaging [J].
Elsholtz, Fabian Henry Juergen ;
Erxleben, Christoph ;
Bauknecht, Hans-Christian ;
Dinkelborg, Patrick ;
Kreutzer, Kilian ;
Hamm, Bernd ;
Niehues, Stefan Markus .
EUROPEAN RADIOLOGY, 2021, 31 (08) :6295-6304
[9]   Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: When do the ends justify the means? [J].
Goodwin, WJ .
LARYNGOSCOPE, 2000, 110 (03) :1-18
[10]   Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months? [J].
Gore, A. ;
Baugnon, K. ;
Beitler, J. ;
Saba, N. F. ;
Patel, M. R. ;
Wu, X. ;
Boyce, B. J. ;
Aiken, A. H. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2020, 41 (07) :1238-1244